Recommandations précédentes
Recommandations précédentes
Recommandations précédentes
Conformément au règlement REACH, l'ECHA doit recommander à partir de la «liste des substances candidates» les substances prioritaires à inclure dans l'annexe XIV de REACH (la «liste d’autorisation») et proposer à la Commission européenne les entrées à inscrire dans l'annexe XIV pour ces substances (c'est-à-dire les dispositions transitoires et, le cas échéant, les exemptions et les périodes de révision), en tenant compte de l'avis du comité des États membres. La Commission européenne décide finalement, en application de la procédure de «comitologie» (contrôle), des substances qui seront incluses dans l'annexe XIV et des entrées correspondantes.
Le tableau ci-dessous comprend toutes les substances qui ont été incluses dans les projets de recommandation ou les recommandations finales de l'ECHA en vue de leur inclusion dans la liste des substances candidates de l'annexe XIV. Dans la colonne «Statut», il est indiqué si l'inclusion des substances a été recommandée ou si elles sont déjà incluses dans l'annexe XIV. Vous pouvez accéder aux documents relatifs aux recommandations en cliquant sur le bouton «Détails» à côté des substances.
Les substances qui ne sont pas recommandées lors d'une session d'examen donnée (statut: «non recommandée dans cette session d'examen») font l'objet d'une nouvelle évaluation lors de sessions suivantes. Par conséquent, il est recommandé de faire une recherche par substance dans le tableau (nom/numéro CE/numéro CAS) pour obtenir le statut le plus récent.
Submitted recommendations
- 10th Annex XIV recommendation 14 April 2021 [PDF][EN]
- 9th Annex XIV recommendation 1 October 2019 [PDF][EN]
- Amendment recommendation 10 July 2019 [PDF][EN]
- 8th Annex XIV recommendation 5 February 2018 [PDF][EN]
- 7th Annex XIV recommendation 10 November 2016 [PDF][EN]
- 6th Annex XIV recommendation 1 July 2015 [PDF][EN]
- 5th Annex XIV recommendation 6 February 2014 [PDF][EN]
- 4th Annex XIV recommendation 17 January 2013 [PDF][EN]
- 3rd Annex XIV recommendation 20 December 2011 [PDF][EN]
- 2nd Annex XIV recommendation 17 December 2010 [PDF][EN]
- 1st Annex XIV recommendation 1 June 2009 [PDF][EN]
There are currently no ongoing consultations.
| Octamethylcyclotetrasiloxane (D4) | 209-136-7 | 556-67-2 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Decamethylcyclopentasiloxane (D5) | 208-764-9 | 541-02-6 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Dodecamethylcyclohexasiloxane (D6) | 208-762-8 | 540-97-6 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Terphenyl, hydrogenated | 262-967-7 | 61788-32-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Dicyclohexyl phthalate (DCHP) | 201-545-9 | 84-61-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Disodium octaborate | 234-541-0 | 12008-41-2 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Benzene-1,2,4-tricarboxylic acid 1,2-anhydride (trimellitic anhydride, TMA) | 209-008-0 | 552-30-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| 4,4'-isopropylidenediphenol (bisphenol A; BPA) | 201-245-8 | 80-05-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP) with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE) | 239-622-4 | 15571-58-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) | 209-218-2 | 561-41-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Dioxobis(stearato)trilead | 235-702-8 | 12578-12-0 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Fatty acids, C16-18, lead salts | 292-966-7 | 91031-62-8 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trilead dioxide phosphonate | 235-252-2 | 12141-20-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Sulfurous acid, lead salt, dibasic | 263-467-1 | 62229-08-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| [Phthalato(2-)]dioxotrilead | 273-688-5 | 69011-06-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trilead bis(carbonate) dihydroxide | 215-290-6 | 1319-46-6 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Lead oxide sulfate | 234-853-7 | 12036-76-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 |
85-42-7 13149-00-3 14166-21-3 |
9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 |
25550-51-0 19438-60-9 48122-14-1 57110-29-9 |
9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Tetraethyllead | 201-075-4 | 78-00-2 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-methoxyethanol | 203-713-7 | 109-86-4 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-ethoxyethanol | 203-804-1 | 110-80-5 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters; 1,2-benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) |
271-094-0 272-013-1 |
68515-51-5 68648-93-1 |
8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 1-Methyl-2-pyrrolidone (NMP) | 212-828-1 | 872-50-4 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| 2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol (UV-327) | 223-383-8 | 3864-99-1 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) | 247-384-8 | 25973-55-1 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol (UV-350) | 253-037-1 | 36437-37-3 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320) | 223-346-6 | 3846-71-7 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2] [covering any of the individual stereoisomers of [1] and [2] or any combination thereof] (karanal group) | - | - | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear | 271-093-5 | 68515-50-4 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Dihexyl phthalate | 201-559-5 | 84-75-3 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 |
85-42-7 13149-00-3 14166-21-3 |
7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 |
25550-51-0 19438-60-9 48122-14-1 57110-29-9 |
7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Trixylyl phosphate | 246-677-8 | 25155-23-1 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Sodium perborate; perboric acid, sodium salt |
239-172-9 234-390-0 |
- | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Sodium peroxometaborate | 231-556-4 | 7632-04-4 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Orange lead (lead tetroxide) | 215-235-6 | 1314-41-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Lead monoxide (lead oxide) | 215-267-0 | 1317-36-8 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Pentalead tetraoxide sulphate | 235-067-7 | 12065-90-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Tetralead trioxide sulphate | 235-380-9 | 12202-17-4 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich | 276-158-1 | 71888-89-6 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters | 271-084-6 | 68515-42-4 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dipentylester, branched and linear | 284-032-2 | 84777-06-0 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1-bromopropane (n-propyl bromide) | 203-445-0 | 106-94-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 4-Nonylphenol, branched and linear, ethoxylated [substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof] | - | - | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Acetic acid, lead salt, basic | 257-175-3 | 51404-69-4 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Anthracene oil | 292-602-7 | 90640-80-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.